Das metastasierte Mammakarzinom – Hoffnungsschimmer am Horizont?Metastatic breast cancer—hope on the horizon?

被引：0

作者：

David Krug ^{[1
]}

Diana Lüftner ^{[2
]}

Klaus Höffken ^{[3
]}

Christiane Bruns ^{[4
]}

机构：

[1] Universitätsklinikum Schleswig-Holstein (UKSH),Klinik für Strahlentherapie

[2] Campus Kiel,Klinik und Poliklinik für Allgemein‑, Viszeral‑, Tumor

[3] Immanuel Klinik Märkische Schweiz, und Transplantationschirurgie

[4] Medizinische Hochschule Brandenburg Theodor Fontane,undefined

[5] Uniklinik Köln,undefined

来源：

Die Onkologie | 2024年 / 30卷 / 6期

关键词：

D O I：

10.1007/s00761-024-01519-w

中图分类号：

学科分类号：

摘要：

引用

页码：444 / 447

页数：3

共 18 条

[1]

Hlevnjak M(2021)CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer Jco Precis Oncol 5 676-686

[2]

Schulze M(2022)Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer New Engl J Med 387 9-20

[3]

Elgaafary S(2020)Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer New Engl J Med 382 597-609

[4]

Modi S(2024)Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer N Engl J Med 390 875-888

[5]

Jacot W(2023)Initial cancer treatment in certified versus non-certified hospitals Dtsch Ärzteblatt Int 120 647-654

[6]

Yamashita T(2021)Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting Diagnostics 11 733-undefined

[7]

Murthy RK(undefined)undefined undefined undefined undefined-undefined

[8]

Loi S(undefined)undefined undefined undefined undefined-undefined

[9]

Okines A(undefined)undefined undefined undefined undefined-undefined

[10]

Powles T(undefined)undefined undefined undefined undefined-undefined

← 1 2 →